Zacks Investment Research on MSN6 天
OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek
Shares of OptiNose OPTN soared 52.5% on Thursday after the company announced that it is set to be acquired by Paratek ...
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion ...
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10‑million‑patient marketAcquisition advances Paratek’s ...